Alyssum Therapeutics
Cambridge
About Alyssum Therapeutics
Alyssum Therapeutics is a biotechnology company that focuses on developing next-generation immunotherapies to modulate B cells.
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $26.0M
- Funding stage: Early Stage Venture
- Last round: Series A (Oct 2024)
- Website: alyssumtx.com
Industries & Categories
Biotechnology, Health Care, Product Research
Social Profiles
Canonical: https://fsome.com/organization/alyssum-therapeutics-1497 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.